The New York Times Trends

The makers of the Pfizer-BioNTech Covid vaccine will soon ask regulators to approve its use in children 5 years and over, and are getting ready to make smaller doses of the vaccine for younger children, according to a BioNTech founder.
See what's buzzing on The New York Times in your native language on